Medical Communications
Mind the gap: men’s health and the need for progress
May 12, 2025 Advocacy Development, Medical Communications, Medical Education, Research and Development Androlabs, Men's Health Strategy, Men's mental health, Movember Foundation, Pharmacy, Psychiatry, mental health
Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
May 7, 2025 Business Services, Medical Communications Digital Control Room, King's Award for Enterprise, Pharma services, Pharmacy, UK
Ambitious plans for leading cancer research centre announced
May 2, 2025 Market & Product Development, Medical Communications, Research and Development Aviva Capital Partners (ACP), Institute of Cancer Research (ICR), London, London Cancer Hub, Oncology, Royal Marsden NHS Foundation Trust, Socius
Pharma supply chain event LogiPharma celebrates another successful year
April 28, 2025 Industry Associations, Medical Communications Cold Chain Technologies, DB Schenker, LogiPharma, Pharmacy, PluumoPlus, supply chain event, supply chain professionals
Kidney Research UK backs digital innovation to support 15 million patients with long-term conditions
April 22, 2025 Medical Education, Patient Awareness Programmes, Public Relations Cognitant Group, Kidney Research UK, Nephrology, chronic kidney disease (CKD)
Survey suggests Britons with a disability are concerned over AI-integrated healthcare
April 14, 2025 Business Services, Consultancy, Medical Communications AI, Consultancy, Corporate, Pharmacy, nuom, survey
Bayer UK Launches New CanesMeno® Educational Hub and Product Range to Transform Menopause Support
January 30, 2025 Medical Communications
Pharmapack Europe the ‘Heart of Pharma’ Start-ups in Paris
January 23, 2025 Medical Communications, Public Relations Heart of Pharma, Paris, pharmapack
Pharma services boom in China as CPHI & PMEC China posts record attendance
August 8, 2024 Conferencing, Events & Incentives, Public Relations, Sales and Marketing CPHI China, PMEC China, pharma
Adaptimmune receives US FDA Accelerated Approval for engineered cell therapy for a solid tumour
August 2, 2024 Medical Communications Adaptimmune, Oncology, accelerated approval, engineered cell therapy, oncology, synovial sarcoma
INDEPENDENT PARSORTIX STUDY HIGHLIGHTS BENEFITS OF COMBINED DNA ANALYSIS IN MELANOMA
August 1, 2024 Medical Communications, Research and Development Angle, Internal Medicine, Oncology, Parsortix, melanoma
Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University
July 31, 2024 Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research
FDA release statement exercising caution around dosing errors associated with compounded injectable semaglutide products
July 31, 2024 Media Relations, Medical Communications, Pharmacovigilance, US Healthcare & Trade Press FDA, Gastrointestinal tract, compunded injectable, dosage, hospitalisation, pharmaceutical, warning
BioAtla gains FDA Fast Track Designation for ozuriftamab vedotin
July 25, 2024 Medical Communications BioAtla, FDA, Oncology, fast track designation, ozuriftamab vedotin
J&J seeks FDA approval of Spravato as monotherapy for treatment-resistant depression
July 24, 2024 Medical Communications J&J, Johnson & Johnson, Neurology, Spravato, treatment-resistant depression
